ATR and PARP inhibition enhances topoisomerase I-dependent DNA damage in colon cancer cell lines

被引：0
|
作者：
Abu-Sanad, Atlal [1 ]
Davidson, David [1 ]
Wang, Yunzhe [1 ]
Pollard, John [2 ]
Aloyz, Raquel [1 ]
Panasci, Lawrence [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Vertex Pharmaceut, Abingdon, Oxon, England
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 05期
关键词：
D O I：
10.1158/1535-7163.PMS-B13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B13
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
    Abu-Sanad, Atlal
    Wang, Yunzhe
    Hasheminasab, Fatemeh
    Panasci, Justin
    Noe, Alycia
    Rosca, Lorena
    Davidson, David
    Amrein, Lilian
    Sharif-Askari, Bahram
    Aloyz, Raquel
    Panasci, Lawrence
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [2] Simultaneous inhibition of ATR and PARP greatly sensitizes colon cancer cell lines to irinotecan
    Davidson, David
    Abu-Sanad, Atlal
    Wang, Yunzhe
    Hasheminasab, Fatemeh
    Panasci, Justin
    Aloyz, Raquel
    Panasci, Lawrence
    CANCER RESEARCH, 2015, 75
  • [3] DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition
    Hayes, Madeline N.
    Cohen-Gogo, Sarah
    Kee, Lynn
    Layeghifard, Mehdi
    Valencia-Sama, Ivette
    Rajaselvam, Anisha
    Kaplan, David
    Villani, Anita
    Shlien, Adam
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    CANCER RESEARCH, 2024, 84 (17)
  • [4] Tyrosyl-DNA phosphodiesterase 1 as a topoisomerase I-dependent cellular poison
    Jafari, Nauzanene
    Gajewski, Stefan
    Bjornsti, Mary-Ann
    White, Stephen
    van Waardenburg, Robert
    CANCER RESEARCH, 2009, 69
  • [5] DNA damage response mutations enhance the antitumor efficacy of ATR and PARP inhibitors in cholangiocarcinoma cell lines
    Lerksuthirat, Tassanee
    Prasopporn, Sunisa
    Wikiniyadhanee, Rakkreat
    Chitphuk, Sermsiri
    Stitchantrakul, Wasana
    Owneium, Paravee
    Jirawatnotai, Siwanon
    Dejsuphong, Donniphat
    ONCOLOGY LETTERS, 2025, 29 (03)
  • [6] Inhibition of DNA topoisomerase I and growth inhibition of human cancer cell lines by an oleanane from Junellia aspera (Verbenaceae)
    Pungitore, C. R.
    Padron, J. M.
    Leon, L. G.
    Garcia, C.
    Ciuffo, G. M.
    Martin, V. S.
    Tonn, C. E.
    CELLULAR AND MOLECULAR BIOLOGY, 2007, 53 (03) : 13 - 17
  • [7] Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy
    Takashima, H
    Boerkoel, CF
    John, J
    Saifi, GM
    Salih, MAM
    Armstrong, D
    Mao, YX
    Quiocho, FA
    Roa, BB
    Nakagawa, M
    Stockton, DW
    Lupski, JR
    NATURE GENETICS, 2002, 32 (02) : 267 - 272
  • [8] INHIBITION OF TOPOISOMERASE I BY ERLOTINIB IN CANCER CELL LINES: EFFICACY OF COMBINED TREATMENTS WITH ERLOTINIB AND TOPOISOMERASE INHIBITOR
    Peleg, Refael
    Bobilev, Dmitri
    Priel, Esther
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3452 - 3453
  • [9] Combined topoisomerase I inhibition for the treatment of metastatic colon cancer
    Holcombe, RF
    Kong, KM
    Wimmer, D
    ANTI-CANCER DRUGS, 2004, 15 (06) : 569 - 574
  • [10] Targeting the DNA Damage Response Pathway by Combination of ATR and PARP Inhibition Imparts Synthetic Lethality to Cervical Cancer Cells
    Hill, Marlee
    Elayapillai, Sugantha Priya
    Hannafon, Bethany N.
    Moxley, Katherine
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (10 S): : S1 - S1
12345